Story thread · 3 reports / 2 sources
Definium Therapeutics Announces New Employee Inducement Grants
financialpost.com · 3h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
NEW YORK — Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 32,900 common shares […]
The coverage
- BofA initiates Kanzhun stock coverage with neutral rating
investing.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.